ReviewMolecular cancer therapeutics2019

Targeting the EGFR and Immune Pathways in Squamous Cell Carcinoma of the Head and Neck (SCCHN): Forging a New Alliance.

Nabil F Saba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.